Zai Ahmad

Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease

Florence I. Raynaud, Kevin Petrie, William A. Weiss, 2015, Cancer cell.

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.

Bandana Sharma, Wenchao Wang, Nathanael S Gray, 2012, Cancer cell.